Gsk (GSK) FCF Payout Ratio (2009 - 2026)

Gsk (GSK) has 18 years of FCF Payout Ratio data on file, last reported at 0.31 in Q3 2026.

• For the quarter ending Q3 2026, FCF Payout Ratio changed N/A year-over-year to 0.31; the trailing twelve-month figure through Sep 2026 stood at 0.27 (changed N/A YoY), and the FY2025 full-year result was 0.28, down 8.2% from the prior year.
• FCF Payout Ratio was 0.31 for Q3 2026 at Gsk, down from 0.47 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.94 in Q1 2023 to a low of 0.02 in Q3 2023.
• A 5-year average of 0.35 and a median of 0.32 in 2025 frame the typical range for FCF Payout Ratio.
• The largest YoY upside for FCF Payout Ratio was 389.01% in 2023 against a maximum downside of 82.88% in 2023.
• Gsk's FCF Payout Ratio stood at 0.46 in 2022, then climbed by 26.92% to 0.59 in 2023, then retreated by 28.01% to 0.42 in 2024, then retreated by 21.55% to 0.33 in 2025, then fell by 5.92% to 0.31 in 2026.
• Per Business Quant data, the three most recent FCF Payout Ratio figures were 0.31 in Q3 2026, 0.47 in Q1 2026, and 0.33 in Q4 2025.